logo

For the Inventor, By the Inventor

San Jose, CA, United States of America

Monica H Palme

This inventor holds 10 USPTO granted patents and 1 published patent application, plus 1 CIPO patent and 3 EPO patents. Top assignees: Aryx Therapeutics, Inc., Eisai Company, Limited, Armetheon, Inc.. Active years: 2001-2013.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Monica H Palme. Retrieved from https://idiyas.com/inventor/monica-h-palme

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 10 

% Patents Active = 60.0



Average Co-Inventor Count = 4.7

ph-index = 9

Forward Citations = 306(Granted Patents)


Location History:

  • San Jose, CA (US) (2001 - 2007)
  • Fremont, CA (US) (2007 - 2012)
  • Woburn, MA (US) (2013)

Company Filing History:

goldMedal4 out of 50 
 
Aryx Therapeutics, Inc.
 patents
silverMedal3 out of 677 
 
Eisai Company, Limited
 patents
bronzeMedal1 out of 2 
 
Armetheon, Inc.
 patents
4. 1 out of 200 
 
Daiichi Pharmaceutical Co., Ltd.
 patents
5. 1 out of 12 
 
Essential Therapeutics, Inc.
 patents
6. 1 out of 2 
 
Trine Pharmaceuticals, Inc.
 patents
where one patent can have more than one assignee

Years Active: 2001-2013

Loading Chart...
Loading Chart...
Loading Chart...
10 patents (USPTO):Explore Patents
1. 8524736 - Stereoisomeric compounds and methods for the treatment of gastrointestinal and central nervous system disorders (2013-09-03),
2. 8138204 - Stereoisomeric compounds and methods for the treatment of gastrointestinal and central nervous system disorders (2012-03-20),
3. 8093237 - Dibenzo[b,f][1,4]oxazapine compounds (2012-01-10),
4. 7282509 - Stereoisomeric compounds and methods for the treatment of gastrointestinal and central nervous system disorders (2007-10-16),
5. 7176218 - Stereoisomeric compounds and methods for the treatment of gastrointestinal and central nervous system disorders (2007-02-13),
6. 7056917 - Drug efflux pump inhibitor (2006-06-06),
7. 6689782 - Fungal efflux pump inhibitors (2004-02-10),
8. 6469182 - Intermediates in the preparation of macrocyclic analogs (2002-10-22),
9. 6365759 - Intermediate compounds for preparing macrocylcic analogs (2002-04-02),
10. 6214865 - Macrocyclic analogs and methods of their use and preparation (2001-04-10),

Title: Inventor Monica H Palme - Revolutionizing Technology in San Jose

Introduction: Monica H Palme is a pioneering inventor based in San Jose, CA, known for her groundbreaking contributions to the field of technology. With a passion for innovation and a keen eye for detail, she has made significant strides in various technological advancements.

Latest Patents: Monica H Palme holds several patents in the technology sector, including patents for cutting-edge software applications, innovative hardware designs, and revolutionary AI systems. Her patents have been instrumental in shaping the future of technology.

Career Highlights: Throughout her illustrious career, Monica H Palme has worked with leading tech companies, research institutions, and universities to develop and implement innovative solutions. Her expertise in technology and her creative approach to problem-solving have earned her recognition as a trailblazer in the industry.

Collaborations: Monica H Palme has collaborated with top engineers, designers, and researchers to bring her inventions to life. Her ability to work effectively in multidisciplinary teams has led to the successful development of groundbreaking technologies that have had a lasting impact on the industry.

Conclusion: Inventor Monica H Palme's dedication to innovation and her relentless pursuit of excellence have solidified her reputation as a visionary in the field of technology. Her contributions continue to inspire future generations of inventors and shape the technological landscape for years to come.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…